Impax Laboratories (IPXL) Misses Q2 EPS by 1c
Tweet
Share
E-mailGet Alerts IPXL Hot Sheet
Price: $18.30 --0%
Financial Fact:
Total operating expenses: 107.2M
Today's EPS Names:
VAXX, NMRD, AFIB, More
Financial Fact:
Total operating expenses: 107.2M
Today's EPS Names:
VAXX, NMRD, AFIB, More
Join SI Premium – FREE
Impax Laboratories (NASDAQ: IPXL) reported Q2 EPS of $0.34, $0.01 worse than the analyst estimate of $0.35. Revenue for the quarter came in at $214.2 million versus the consensus estimate of $199.93 million.
For earnings history and earnings-related data on Impax Laboratories (IPXL) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Netflix climbs following Ackman stake, up 1.8%
- Aebi Schmidt Holding AG (AEBI) Reports Q2 results; offers guidance
- Paysafe Limited (PSFE) Misses Q2 EPS by 43c; offers guidance
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
